fbpx

QQQ
+ 2.31
364.32
+ 0.63%
BTC/USD
-1112.17
60560.25
-1.8%
DIA
+ 3.70
345.43
+ 1.06%
SPY
+ 3.26
439.24
+ 0.74%
TLT
-0.85
146.73
-0.58%
GLD
-2.66
170.66
-1.58%

Expert Ratings For Biogen

September 16, 2021 1:22 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Expert Ratings For Biogen

Over the past 3 months, 7 analysts have published their opinion on Biogen (NASDAQ:BIIB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

  Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 2 2 3 0 0
Last 30 Days 1 0 0 0 0
1 Month Ago 0 0 0 0 0
2 Months Ago 1 1 2 0 0
3 Months Ago 0 1 1 0 0

According to 7 analyst offering 12-month price targets in the last 3 months, Biogen has an average price target of $395.43 with a high of $455.00 and a low of $300.00.

Below is a summary of how these 7 analysts rated Biogen over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the move negative analysts are on the stock

price target chart

This current average has increased by 0.76% from the previous average price target of $392.43.

How Are Analyst Ratings Determined?

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.

Posted-In:

Analyst Ratings

Related Articles

Analyst Ratings For Biogen

Analyst Ratings For Biogen

Biogen (NASDAQ:BIIB) has observed the following analyst ratings within the last quarter: read more
Where Biogen Stands With Analysts

Where Biogen Stands With Analysts

Within the last quarter, Biogen (NASDAQ:BIIB) has observed the following analyst ratings: read more
Analyst Ratings For Biogen

Analyst Ratings For Biogen

Over the past 3 months, 10 analysts have published their opinion on Biogen (NASDAQ:BIIB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year. read more
Analyst Ratings For Biogen

Analyst Ratings For Biogen

Biogen (NASDAQ:BIIB) has observed the following analyst ratings within the last quarter: read more